The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 22, 2018
Filed:
Oct. 06, 2016
Applicant:
Genentech, Inc., South San Francisco, CA (US);
Inventors:
Stephan Bachmann, Basel, CH;
Serena Maria Fantasia, Basel, CH;
Francis Gosselin, San Mateo, CA (US);
Chong Han, Foster City, CA (US);
Stefan Hildbrand, Basel, CH;
Theresa Humphries, San Francisco, CA (US);
Christian Jenny, Basel, CH;
Ngiap-Kie Lim, South San Francisco, CA (US);
Andrew McClory, South San Francisco, CA (US);
Christian Moessner, Basel, CH;
Pankaj Rege, Basel, CH;
Scott Savage, Burlingame, CA (US);
Haiming Zhang, San Mateo, CA (US);
Assignee:
Genentech, inc., South San Francisco, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 231/56 (2006.01); C07D 405/04 (2006.01); C07C 309/73 (2006.01); C07C 69/73 (2006.01); C07F 5/04 (2006.01); C07C 69/612 (2006.01); C07F 5/02 (2006.01);
U.S. Cl.
CPC ...
C07D 231/56 (2013.01); C07C 69/612 (2013.01); C07C 69/73 (2013.01); C07C 309/73 (2013.01); C07D 405/04 (2013.01); C07F 5/025 (2013.01); C07F 5/04 (2013.01);
Abstract
Processes are described for the preparation of estrogen receptor modulating compound, (E)-3-(4-((E)-2-(2-chloro-4-fluorophenyl)-1-(1H-indazol-5-yl)but-1-en-1-yl)phenyl)acrylic acid I: